首页>
外国专利>
BIOMARKERS FOR DISTINGUISHING BETWEEN AGGRESSIVE PROSTATE CANCER AND NON-AGGRESSIVE PROSTATE CANCER
BIOMARKERS FOR DISTINGUISHING BETWEEN AGGRESSIVE PROSTATE CANCER AND NON-AGGRESSIVE PROSTATE CANCER
展开▼
机译:区分前列腺癌和非前列腺癌的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the field of biomarkers. More specifically, the present invention relates to biomarkers useful in diagnosing aggressive prostate cancer. In one embodiment, a method for identifying patients as having or likely to have aggressive prostate cancer comprises the steps of (a) performing an assay on a biological sample obtained from the patient to detect fucosylated prostate specific antigen (PSA), transmembrane prostate androgen-induced protein, kallikrein-2, lipid phosphate phosphohydrolase 3, heparan-sulfate 6-O-sulfotransferase, prostatic acid phosphatase (PAP), nuclear RNA export factor 2, and protein POF1B; and (b) identifying the patient as having or likely to have aggressive prostate cancer if there is a statistically significant difference in the levels of fucosylated PSA, transmembrane prostate androgen-induced protein, kallikrein-2, lipid phosphate phosphohydrolase 3, heparan-sulfate 6-O-sulfotransferase, PAP, nuclear RNA export factor 2, and protein POF1B as compared to corresponding levels in a control sample that correlates to non-aggressive prostate cancer.
展开▼